Results 131 to 140 of about 19,127 (267)

Limited association between HRR gene alterations and HRD in molecular tumor board cancer samples: Who should be tested for HRD?

open access: yesInternational Journal of Cancer, Volume 157, Issue 5, Page 964-979, 1 September 2025.
What's new? Currently, no published data on homologous recombination deficiency (HRD) testing in the setting of molecular tumor boards exist. This study in a cohort of 237 patients encompassing 24 different tumor entities assessed by a molecular tumor board shows that inactivating alterations of BRCA1/2 are not always associated with an elevated ...
Christoph Schubart   +26 more
wiley   +1 more source

Gallbladder Mixed Neuroendocrine-Non-neuroendocrine Neoplasm (MiNEN) Arising in Intracholecystic Papillary Neoplasm: Clinicopathologic and Molecular Analysis of a Case and Review of the Literature [PDF]

open access: green, 2020
Amedeo Sciarra   +6 more
openalex   +1 more source

Fucoidan From Brown Algae as a Functional Food Ingredient: A Promising Anticancer Agent

open access: yeseFood, Volume 6, Issue 4, August 2025.
Fucoidan, a bioactive polysaccharide from brown algae, inhibits receptor tyrosine kinase (RTK) activation and vascular endothelial growth factor (VEGF) signaling, suppressing the phosphoinositide 3‐kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) and RAS/RAF/mitogen‐activated protein kinase/extracellular signal‐regulated kinase ...
Muhammad Umer Khan   +7 more
wiley   +1 more source

Intracholecystic Tubulopapillary Neoplasm of the Gallbladder: A Case Report [PDF]

open access: yesAmerican Journal of Clinical Pathology, 2018
Sharmila Ghosh   +2 more
openaire   +2 more sources

What's your diagnosis? Circumferential small intestinal mass in a cat

open access: yes
Veterinary Clinical Pathology, EarlyView.
Cheryl L. Auch, Nutnapong Udomteerasuwat
wiley   +1 more source

GLP‐1 receptor agonists and the risk for cancer: A meta‐analysis of randomized controlled trials

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 8, Page 4454-4468, August 2025.
Abstract Aims To assess if there is a difference in the oncogenic risk between GLP‐1 RA and comparators in randomized controlled trials. Materials and Methods A meta‐analysis of randomized controlled trials comparing GLP‐1RA to any comparators for diabetes and/or obesity, lasting at least 52 weeks.
Giovanni Antonio Silverii   +5 more
wiley   +1 more source

Neuroendocrine Neoplasms of the Gallbladder: A Clinicopathological Analysis of 13 Patients and a Review of the Literature [PDF]

open access: gold, 2021
Pengyan Wang   +6 more
openalex   +1 more source

Sunitinib as Second‐Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the SUN‐CK GERCOR Phase II Trial

open access: yesLiver International, Volume 45, Issue 8, August 2025.
ABSTRACT Background & Aims Angiogenesis is critical in intrahepatic cholangiocarcinoma (ICC), a highly lethal cancer with limited treatment options. Sunitinib, a multi‐receptor tyrosine kinase inhibitor, has strong antiangiogenic and antitumor effects.
Louis Gros   +16 more
wiley   +1 more source

Schistosoma gallbladder polyp masquerading as a neoplasm: Rare case report and literature review [PDF]

open access: green, 2021
Gawahir A. Ali   +4 more
openalex   +1 more source

Liver Involvement in Celiac Disease and Immune‐Mediated Diseases of the Small Bowel

open access: yesLiver International, Volume 45, Issue 8, August 2025.
ABSTRACT Disorders of the hepatobiliary system are commonly associated with gastrointestinal (GI) diseases. The GI and hepatobiliary systems interact through the portal vein system and enterohepatic circulation, creating a gut–liver axis that allows for a complex multidirectional interplay between immune, hormonal, dietary and environmental luminal ...
Nicoletta Nandi   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy